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 to 17 currently identified species
(Table 1). At least six of these (
 
B. bacilliformis, B. henselae,




B. clarridgeiae and B. vinsonni
arupensis
 





knowledge in this field of pathology and the new insights pro-





. and human diseases caused by them will
continue to increase in the coming years.
This review focuses on the cutaneous manifestations of













 In patients with history of cat contact
or scratches, the disease typically presents as a lymphadeno-
pathy preceded by an erythematous papule at the inoculation





 and usually evolves through erythematous,





 Hence, it may still be present as a crusted ery-
thematous papule 2–6 mm in diameter when the regional
lymphadenopathy develops 3–50 days after inoculation. The
histopathology of the skin lesion is similar to the lymph node
changes consisting of a diffuse inflammatory cell infiltrate
associating numerous neutrophils and histiocytes admixed
with scattered eosinophils and plasma cells. Epidermal hyper-
plasia and dermal deposits of proteoglycans may also be




 Warthin-Starry silver stain frequently
Table 1 Bartonella spp. pathogens in humans and animals. 
Adapted from [1,2]
Species




B. bacilliformis 1907 Human Sandfly
B. talpae 1911 Mole
B. quintana 1917 Human Body louse
B. peromysci 1942 Deer, mouse
B. vinsonni vinsonni 1946 Vole
B. henselae 1992 Cat, Human Cat flea
B. elizabethae 1993 Rat, Human
B. grahamii 1995 Mouse, vole
B. taylorii 1995 Mouse, vole
B. doshiae 1995 Vole
B. vinsonni berkhoffi 1996 Dog
B. clarridgeiae 1996 Cat, Human
B. tribocorum 1998 Rat
B. alsatica 1999 Rabbit
B. khoelerae 1999 Cat
B. vinsonni arupensis 1999 Cattle, Human
B. weissii 2000 Cattle, cat Figure 1 Cat scratch disease. Papular lesion at the inoculation 
site
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reveals clustered bacteria within micro-abscesses, with pro-





 Other, more unusual, skin manifestations include
morbilliform eruptions, urticaria, erythema nodosum, ery-
thema multiforme and erythema marginatum.




 is the primary etio-




 Although it is currently impossible to
reproduce CSD in a host other than the cat to fulfill the Koch’s
























 infection despite appropriate search.
For example, when immunofluorescence assay was applied to
serum from patients with the most strictly defined CSD cases,









, initially considered to be the cause of CSD,
is not ruled out, it being possible that this and other bacteria






In the past, trench fever was one of the most widespread barto-
nelloses. Transmitted by the body louse, the disease became
rare after World War II, but surged again during the last decade









, follows a cyclic clinical evo-
lution combining fever, malaise, chills, anorexia, sweating,
headache, conjunctival injection, myalgias and arthralgias.
About 80–90% of the patients present crops of erythe-
matous macules or papules measuring 1 cm or less on the




 These cutaneous manifestations
have not been thoroughly studied using histopathology. As
the condition is quite fleeting, it would be expected to demon-






The first case of bacillary angiomatosis (BA) was reported












 were demonstrated from cutaneous lesions and
blood of affected individuals by direct cultivation and polymerase




AIDS-associated BA was most frequently seen when the




















 Bacillary angiomatosis was identi-
fied in different tissues including skin, brain, bone, lymph nodes,




Epidemiological studies have shown skin lesions to be the
most frequent clinical manifestation of the disease, ranging




 It is noteworthy that the
incidence of BA has been dramatically reduced since the intro-
duction of AIDS tritherapy and prophylactic antibiotherapy.
The typical lesion is solitary or dispersed all over the body.
The reddish-purple papule about 1 cm in diameter (Fig. 2)
and may be difficult to differentiate clinically from Kaposi’s




making it mandatory to examine a skin biopsy to confirm the
diagnosis. Other BA lesions present under different aspects
including smooth, warty and pedunculated papules, as well as
subcutaneous nodules and hyperkeratotic plaques. They are




There is a current trend to curb the BA incidence, probably
due to the extensive use of antimicrobial drugs as prophy-




 In the USA,














 has only recently been





is a lack of information about the causative organism(s) in
the other continents. From the few reports available where
serious efforts were made to identify the bacteria, there is at
least one unsuccessful attempt; interestingly in two immuno-
competent individuals with lesions histologically mimicking BA




 These findings leave an open




. or bacteria in BA
lesions. The microbiological characterization of BA should be



























 Both micro-organisms have a similar
Figure 2 Bacillary angiomatosis in a cardiac transplant patient
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ability to produce cutaneous lesions but, while the latter is




 is associated with a greater propensity to produce




 Liver peliosis is somewhat
microscopically different from BA. This difference may reflect
particular characteristics of this organ such as the proportion









 produces CSD in some cases




 produces diseases as
distinct as trench fever, endocarditis and BA. It is obvious that
an as yet unidentified immunological parameter of the host
influences the different clinical manifestations of these bar-
tonelloses. While the immune status clearly affects the clin-
















salient features are a lobular accumulation of rounded blood
vessels with plump endothelial cells. Cell necrosis, atypia and
mitoses are especially found in densely cellular areas. A mixed
inflammatory cell infiltrate with predominance of neutrophils
and occasional leukocytoclasia is also present. Granular eosi-
nophilic and Warthin-Starry-positive bacilli are the hallmark
of the lesion. In addition, numerous Factor XIIIa’s-positive




 There is indeed
increasing evidence regarding the immunological activity of














Detailed reviews have been presented about the etiology,









, the etiologic agent of




genus. The disease is typically confined to Andean valleys of
Peru, Colombia and the Equator, due to the ecologic distribu-






Verruga peruana is an eruptive angiomatous disease of the
skin (Figs 3 and 4) that typically develops 2 months after an
acute phase of bacteriemic disease known as Oroya fever or










 There is a great histological similarity





ever, verruga peruana differs from BA at the microscopical
level, at least by the lack of aggregates of bacilli (Table 2).
Actually, verruga peruana does not seem to be confined to
the recognized epidemiological villages where it was originally
documented anymore. We have indeed seen some cases of
angiomatous lesions resembling verruga peruana in appar-
ently immunocompetent individuals without any recognized














 some of these angio-
matous lesions with incomplete or absent epidemiological









. On the other hand, there are





 in HIV-infected individuals. Finally,
the immunodeficiency status associated with the majority of
cases of BA, mainly CD4+ lymphocyte depletion and phago-
cytic dysfunction, could be compared with the immunological




 This could provide a
suitable model of the influence of the immunological status on
the development of some vascular lesions of the skin.
Figure 3 Verruga peruana. Two small papules on the face
Figure 4 Verruga peruana, nodular type
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Skin and the immune system in bartonelloses
 
The skin-restricted features of verruga peruana and the pre-
dominant skin manifestations in BA together with the immuno-
logical impaired status found in both diseases make it
attractive to suggest a common pathobiological pathway. The
skin might be a target of specific infectious agents responsible
for angiomatous diseases in the setting of impaired immune
function. Indeed, angiogenesis is a biological event strictly
controlled and associated with wound healing, several










lesions may represent some variants of these angiogenic responses













might also be considered when analyzing the complex inter-
action between bacteria, skin cells and the immune system.
The immune function of the skin was emphasized many
years ago under the concept of ‘skin-associated lymphoid





 The biological interactions between
cutaneous dendritic cells, endothelial cells and skin lym-
phocytes is altered in some pathological conditions. For





 and the vascular proliferation in BA
may represent a defect in the phagocytic function and devel-









 tropism for the skin could
be caused by the better growth of the bacilli at lower temper-








. infections are responsible for different clinical
presentations including vascular growths in the skin. Further
research must be guided in order to identify the whole





responsible for vascular lesions. The cellular and molecular
components of BA and verruga peruana lesions should be
scrutinized. Some analogy among these diseases could pro-



























Table 2 Similarities and differences between verruga peruana and bacillary angiomatosis
VERRUGA PERUANA BACILLARY ANGIOMATOSIS
Etiology Etiology
B. bacilliformis B. henselae, B. quintana, other Bartonella species?
Epidemiology Epidemiology
Confined to Andean valleys of Peru, Colombia 
and Equator
Worldwide distribution
No healthy carrier status proved in humans
Existence of an asymptomatic status carrier Body louse(also head louse) is the vector of B. quintana
Lutzomyia verrucarum is the sole vector known Cats, in particular kittens, are the reservoir of B. henselae
Animal reservoir not known but presumed No animal model has been demonstrated for B. quintana
Monkey is the sole proved animal model for the 
eruptive phase of the disease
Clinical presentation Clinical presentation
Usually a two-stage disease, preceded by an 
hemolytic phase followed by the eruptive one
Skin lesions occurring as papules, warts, pedunculated, 
subcutaneous nodules (rarely ulcerated or bleeding), or 
hyperkeratotic plaques 
Clinically these lesions look similar to verruga peruana
Natives are more prone to develop just 
the eruptive phase
Foreign people usually develop devastating disease
Immune status of the host Immune status of the host
Impaired immunity in hemolytic phase of the disease The vast majority of cases occurring in HIV-positive and other
with propensity to develop opportunistic infections 
Decreased CD4-T lymphocytes and augment of CD8-T
immunodeficiency status, however, there are reported cases 
in apparently immunocompetent individuals
lymphocytes in peripheral blood with 
inversion of the CD4/CD8 ratio
There is no information concerning the possible direct effect of 
B. henselae and B. quintana on the immune status of the host
Lesser degree of impaired cellular immune function 
Acute infection induces impaired immune function that 
precedes development of angiomatous lesions
Natural history Natural history
Skin lesions of verruga peruana regress spontaneously 
with little benefit of antibiotic therapy
Lesions resolve with antimicrobial therapy, 
better response in immunosuppressed individuals
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